BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 22766684)

  • 1. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.
    Syed AU; Koide M; Braas KM; May V; Wellman GC
    J Mol Neurosci; 2012 Nov; 48(3):574-83. PubMed ID: 22766684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP and its receptors in cranial arteries and mast cells.
    Jansen-Olesen I; Hougaard Pedersen S
    J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
    Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
    Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
    Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
    Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
    Girard BM; Tompkins JD; Parsons RL; May V; Vizzard MA
    J Mol Neurosci; 2012 Nov; 48(3):730-43. PubMed ID: 22700375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism.
    Takács-Lovász K; Kun J; Aczél T; Urbán P; Gyenesei A; Bölcskei K; Szőke É; Helyes Z
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
    Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
    Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
    Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
    Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery.
    Tasma Z; Siow A; Harris PWR; Brimble MA; Hay DL; Walker CS
    Br J Pharmacol; 2022 Feb; 179(3):435-453. PubMed ID: 34612509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina.
    Lakk M; Szabó B; Völgyi B; Gábriel R; Dénes V
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7825-32. PubMed ID: 23099490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons.
    DeHaven WI; Cuevas J
    Neurosci Lett; 2002 Aug; 328(1):45-9. PubMed ID: 12123856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.